secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyra Therapeutics, Inc. (LYRA)
CIK:        0001327273
Form:       8-K
Filed at:   2026-04-17T23:59:59+00:00
Accession:  0001193125-26-160421
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Lyra Therapeutics terminates Waltham sublease; pays $2.1M termination fee
-------------------------------------------------------------------------

- Termination of sublease for 23,704 sq ft at 880 Winter Street, Waltham, MA, effective March 31, 2026.
- Company pays $2,100,000 termination payment; rent obligations ceased January 31, 2026.
- Upon surrender and payment, RVAC Medicines will release $600,501 letter of credit security deposit.
- Sublease originally dated December 21, 2023; premises must be surrendered by May 31, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1327273/000119312526160421/0001193125-26-160421-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1327273/000119312526160421/d121976d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-160421

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer